¿Cómo defino una meta “alcanzable” para mi paciente con Obesidad?

Cédula: 7187335

Y la Dra. Araceli Díaz Polanco. Especialista en Endocrinología. Hospital Star Médica Morelia

Cédula: 9585859

Estimado Dr. (a)

Lo invitamos cordialmente a ver la videocápsula: “¿Cómo defino una meta “alcanzable” para mi paciente con Obesidad, en comparación con una meta “ideal”?”

Referencias:

1. Factsheet 311. 2014. http://www.who.int/
2. Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009 Mar 28; 373(9669): 1083–1096.
3. Badman MK, et al. The Gut and Energy Balance: Visceral Allies in the Obesity Wars. Science 2005;307:1909–14.
4. US Department of Health and Human Services, 1998. NIH Publication No. 98-4083. https://www.nhlbi.nih.gov/files/docs/guidelines/ob_gdlns.pdf
5. Sharma AM. M, M, M & M: A Mnemonic for Assessing Obesity. Obes Rev. 2010;11:808-9.
6. Guh DP, et al. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health 2009;9:88.
7. Luppino FS, et al. Overweight, Obesity, and Depression: A Systematic Review and Meta-Analysis of Longitudinal Studies. Arch Gen Psychiatry 2010;67:220–9.
8. Simon GE, et al. Association Between Obesity and Psychiatric Disorders in the US Adult Population. Arch Gen Psychiatry 2006;63:824–30.
9. Church TS, et al. Association of Cardiorespiratory Fitness, Body Mass Index, and Waist Circumference to Nonalcoholic Fatty Liver Disease. Gastroenterology 2006;130:2023–30.
10. Li C, et al. Prevalence of Self-Reported Clinically Diagnosed Sleep Apnea According to Obesity Status in Men and Women: National Health and Nutrition Examination Survey, 2005-2006. Prev Med 2010;51:18–23.
11. Hosler AS. Prevalence of Self-Reported Prediabetes Among Adults Participating in a Community-Based Health Awareness Program, New York State. Prev Chronic Dis 2009;6:A48
12. Knowler WC, et al. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. N Engl J Med. 2002;346(6):393-403.
13. Wing RR, et al. Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals with Type 2 Diabetes. Diabetes Care. 2011;34(7):1481-1486.
14. Riddle DL, et al. Body weight changes and corresponding changes in pain and function in persons with symptomatic knee osteoarthritis: a cohort study. Arthritis Care Res (Hoboken). 2013;65(1):15-22.
15. Tuomilehto H, et al. The Impact of Weight Reduction in the Prevention of the Progression of Obstructive Sleep Apnea: An Explanatory Analysis of a 5-year Observational Follow-Up Trial. Sleep Med. 2014;15(3):329-335.
16. Foster GD, et al. A Randomized Study on the Effect of Weight Loss on Obstructive Sleep Apnea Among Obese Patients with Type 2 Diabetes: The Sleep AHEAD Study. Arch Intern Med. 2009;169(17):1619-1626.
17. Warkentin LM, et al. The effect of weight loss on health-related quality of life: systematic review and meta-analysis of randomized trials. Obes Rev. 2014;15(3):169-182.
18. Garber AJ, et al. AACE/ACE Comprehensive Diabetes Management Algorithm 2015. Endocrine Practice: April 2015, Vol. 21, No. 4, pp. 438-447.
19. Sharma AM, et al. A Proposed Clinical Staging System for Obesity. Int J Obes (Lond) 2009;33:289–95.

20. FDA Drugs: http://www.fda.gov/Drugs/default.htm
21. EMA Medicines: http://www.ema.europa.eu/

Material desarrollado con fines de educación médica continua.

Código interno de aprobación: MX20OB00003.

Material exclusivo para profesionales de la salud.

La información aquí presentada es la opinión del ponente.